
Title: FDA Issues Warning Letters to Dexcom for Violations at Two US Manufacturing Sites: What It Means for Investors and Consumers
Dexcom Receives FDA Warning Letter: A Significant Setback for the Medical Device Industry In a recent development that has sent shockwaves through the medical device industry, Dexcom Inc., a leading player in continuous glucose monitoring systems, announced that it had received a warning letter from the U.S. Food and Drug Administration (FDA) following inspections of…